The Supreme Court faces a crucial decision on President Donald Trump's tariffs. Businesses and states are challenging these ...
Sarepta (SRPT) announced the completion of the confirmatory trial commitment for its ultra-rare disease PMO therapies AMONDYS 45 and VYONDYS 53: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback